|Mr. Jean-Paul Agon||Chairman & CEO||4.37M||N/A||1956|
|Mr. Christophe Babule||Exec. VP & CFO||N/A||N/A||1965|
|Mr. Antoine Vanlaeys||Chief Operations Officer||N/A||N/A||N/A|
|Ms. Barbara Lavernos||Pres of Research, Innovation & Technology||N/A||N/A||1968|
|Ms. FranÃ§oise Lauvin||Head of Investor Relations||N/A||N/A||N/A|
|Ms. Blanca Juti||Chief Communications & Public Affairs Officer||N/A||N/A||1968|
|Mr. Jean-Claude Le Grand||Chief Human Relations Officer||N/A||N/A||1965|
|Mr. Nicolas Hieronimus||Deputy CEO & Head of Divisions||N/A||N/A||1964|
|Mr. FrÃ©dÃ©ric RozÃ©||Chief Global Growth Officer||N/A||N/A||1961|
|Mr. Alexandre Popoff||Pres of Eastern Europe Zone||N/A||N/A||1961|
L'OrÃ©al S.A., through its subsidiaries, manufactures and sells cosmetic products for women and men worldwide. The company operates through four divisions: Consumer Products, L'orÃ©al Luxe, Professional Products, and Active Cosmetics. It offers shampoos, hair care products, shower gels, skin care products, cleansers, hair colors, styling products, deodorants, sun care products, make-up, perfumes, etc. The company provides its products under the L'OrÃ©al Paris, Garnier, Maybelline New York, NYX Professional Makeup, Essie, Niely, Dark and Lovely, LancÃ´me, Yves Saint Laurent BeautÃ©, Giorgio Armani Beauty, Kiehl's, Urban Decay, Biotherm, Ralph Lauren, IT Cosmetics, L'OrÃ©al Professionnel, KÃ©rastase, Redken, Matrix, Biolage, Pureology, DeclÃ©or, Carita, Vichy, La Roche-Posay, SkinCeuticals, Roger&Gallet, CeraVe, Stylenanda, Mixa, Magic Mask, Prada, Helena Rubinstein, Valentino, Mugler, Shu Uemura, Viktor&Rolf, Azzaro, Diesel, Atelier Cologne, Cacharel, and Yue Sai brands. It sells its products through distribution channels, such as hair salons, mass-market retail channels, perfumeries, department stores, pharmacies, drugstores, medispas, branded retail, travel retail, and e-commerce. The company was founded in 1909 and is headquartered in Clichy, France.
L'Oréal S.A.’s ISS governance QualityScore as of 1 April 2021 is 2. The pillar scores are Audit: 4; Board: 3; Shareholder rights: 5; Compensation: 2.